Neurological Surgery 脳神経外科50巻4号

2022年07月発行

特集 STA-MCAバイパス術—日本が世界に誇る技を学ぶ Ⅲ特殊なバイパス術

もやもや病に対するバイパス術Ⅰ：その特殊性，成人例に対する私の手術法

著者： 黒田敏¹

所属機関： ¹富山大学医学部脳神経外科

ページ範囲：P.806 - P.818

Point
・診断と適応決定，手術デザイン，周術期管理がバイパス術の成否を決める．
・確固たる技術的・心理的自信をもって手術に臨む．
・術者は長期間の経過観察に責任を有する．

参考文献

1）米川泰弘：脳神経外科手術手技に関する私見と歴史的背景．9．モヤモヤ病．No Shinkei Geka 40：67-87, 2012

2）Karasawa J, et al：A surgical treatment of “moyamoya” disease “encephalo-myo-synangiosis”. Neurol Med Chir（Tokyo）17（1 Part 1）：29-37, 1977

3）Kaku Y, et al：Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image：is arterial constrictive remodeling a major pathogenesis? Acta Neurochir（Wien）154：2151-2157, 2012

4）Kuroda S, et al：Specific shrinkage of carotid forks in moyamoya disease：a novel key finding for diagnosis. Neurol Med Chir（Tokyo）55：796-804, 2015

5）Yamamoto S, et al：Progressive shrinkage of involved arteries in parallel with disease progression in moyamoya disease. World Neurosurg 122：e253-e261, 2019　doi：10.1016/j.wneu.2018.10.001

6）Yamamoto S, et al：Stenosis severity-dependent shrinkage of posterior cerebral artery in moyamoya disease. World Neurosurg 126：e661-e670, 2019　doi：10.1016/j.wneu.2019.02.120

7）Yamamoto S, et al：Is quasi-moyamoya disease a uniform disease entity? A three-dimensional constructive interference in steady state imaging study. J Stroke Cerebrovasc Dis 25：1509-1516, 2016

8）黒田　敏，他：もやもや病診断基準—2021年改訂版．脳卒中の外 50：1-7, 2022

9）Kuroda S, et al：Diagnostic Criteria for Moyamoya Disease-2021 Revised Version. Neurol Med Chir（Tokyo）Neurol Med Chir（Tokyo）, 2022（Online ahead of print）　doi：10.2176/jns-nmc. 2022-0072.

10）Kuroda S, et al：Regional cerebral hemodynamics in childhood moyamoya disease. Childs Nerv Syst 11：584-590, 1995

11）Kuroda S, et al：Novel bypass surgery for moyamoya disease using pericranial flap:its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery 66：1093-1101, 2010

12）Kuroda S, et al：Late（5-20 years）outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease. J Neurosurg 134：909-916, 2020

13）Miyamoto S, et al；JAM Trial Investigators：Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease：results of the Japan Adult Moyamoya Trial. Stroke 45：1415-1421, 2014

14）JET Study Group：Japanese EC-IC Bypass Trial（JET Study）—中間解析結果（第二報）．脳卒中の外 30：434-437, 2002

O-PET study. Diagnostics（Basel）11：1820, 2021　doi：10.3390/diagnostics11101820

O-gas positron emission tomographic study. Stroke 45：2717-2721, 2014

17）黒田　敏，他：Acetazolamide負荷によるSEPの変化と脳循環動態の関連について—脳循環予備能障害の診断における有用性と限界について．脳と神経 43：924-930, 1991

18）Funaki T, et al：Angiographic features of hemorrhagic moyamoya disease with high recurrence risk：a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 128：777-784, 2018

19）Funaki T, et al：High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease：analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg 130：525-530, 2019

20）Kuroda S, et al；Research Committee on Moyamoya Disease in Japan：Radiological findings, clinical course and outcome in asymptomatic moyamoya disease：results of multicenter survey in Japan. Stroke 38：1430-1435, 2007

21）Kuroda S；AMORE Study Group：Asymptomatic moyamoya disease：literature review and ongoing AMORE study. Neurol Med Chir（Tokyo）55：194-198, 2015

22）Ishikawa T, et al：Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 28：1170-1173, 1997

23）Uchino H, et al：Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease：a serial single photon emission CT/positron emission tomography study. Stroke 43：2610-2616, 2012

24）Uchino H, et al：Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease：historical control study. Stroke 47：1930-1932, 2016

25）Nakagawa Y, et al：Revascularization surgery for moyamoya disease. Neurol Res 10：32-39, 1988

26）Hori S, et al：Surgical anatomy and preservation of the middle meningeal artery during bypass surgery for moyamoya disease. Acta Neurochir（Wien）157：29-36, 2015

27）Kamiyama H, et al：Visualization of the ostium of an arteriotomy in bypass surgery. Neurosurgery 33：1109-1110, 1993

28）Uchino H, et al：Synergistic interactions between direct and indirect bypasses in combined procedures：the significance of indirect bypasses in moyamoya disease. Neurosurgery 80：201-209, 2017

29）Uchino H, et al：Using postoperative remodeling of donor arteries on MR angiography to predict development of surgical collaterals in moyamoya disease. J Neurosurg 134：1-9, 2021（Online Publication Date：8 Nov 2019）

30）Yamamoto S, et al：Ameliorative effects of combined revascularization surgery on abnormal collateral channels in moyamoya disease. J Stroke Cerebrovasc Dis 30：105624, 2021　doi：10.1016/j.jstrokecerebrovasdis. 2021.105624

31）Bao XY, et al：Long-term outcomes after encephaloduroarteriosynangiosis in adult patients with moyamoya disease presenting with ischemia. World Neurosurg 115：e482-e489, 2018　doi：10.1016/j.wneu.2018.04.076

32）Mukawa M, et al：Long-term follow-up of surgically treated juvenile patients with Moyamoya disease. J Neurosurg Pediatr 10：451-456, 2012

33）Funaki T, et al：Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease：a descriptive longitudinal study at a single center. Acta Neurochir（Wien）156：551-559；discussion 559, 2014